(NASDAQ: SRRK) Scholar Rock Holding's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.64%.
Scholar Rock Holding's revenue in 2024 is $0.On average, 6 Wall Street analysts forecast SRRK's revenue for 2025 to be $2,251,457,255, with the lowest SRRK revenue forecast at $222,513,841, and the highest SRRK revenue forecast at $7,018,357,720. On average, 7 Wall Street analysts forecast SRRK's revenue for 2026 to be $12,841,999,546, with the lowest SRRK revenue forecast at $3,971,752,437, and the highest SRRK revenue forecast at $22,650,154,460.
In 2027, SRRK is forecast to generate $24,408,173,315 in revenue, with the lowest revenue forecast at $6,834,923,371 and the highest revenue forecast at $38,006,799,676.